Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Merrimack Pharmaceuticals...

    NASDAQ: MACK · Real-Time Price · USD
    15.14
    0.01 (0.07%)
    At close: May 17, 2024, 9:59 PM

    Merrimack Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a
    Cost of Revenue
    		 n/a 445K n/a
    Gross Profit
    		 n/a -445K n/a
    Operating Income
    		 -2.18M -1.73M -2.47M
    Interest Income
    		 868K 188K 20K
    Pretax Income
    		 -1.17M -1.54M -2.45M
    Net Income
    		 -1.18M -1.54M -2.46M
    Selling & General & Admin
    		 2.18M 2.17M 2.62M
    Research & Development
    		 n/a n/a n/a
    Other Expenses
    		 n/a n/a n/a
    Operating Expenses
    		 2.18M 2.17M 2.62M
    Interest Expense
    		 n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 2.18M 2.17M 2.62M
    Income Tax Expense
    		 12K 3K 3K
    Shares Outstanding (Basic)
    		 14.3M 13.52M 13.41M
    Shares Outstanding (Diluted)
    		 14.3M 13.52M 13.41M
    EPS (Basic)
    		 -0.08 -0.11 -0.18
    EPS (Diluted)
    		 -0.08 -0.11 -0.18
    EBITDA
    		 -2.18M -2.62M -2.76M
    EBIT
    		 n/a -1.73M -2.47M
    Depreciation & Amortization
    		 167.9K -890K -288K

    Add to Watchlist